Skip to Main Content
Prescriber's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Site updates: As we launch new branding in the coming months, you will see updates to the logos. This will not impact access to your subscription.
  1. Home
  2. Browse
  3. Gastroenterology
  4. Liver Disease
  5. Hepatitis C

Hepatitis C

  • Bowel Preps (6)
  • Celiac Disease (3)
  • Constipation (55)
  • Crohn's Disease (6)
  • Diarrhea (65)
  • Gallbladder (3)
  • Gastrointestinal Bleeding (172)
  • GERD (85)
  • Heartburn (13)
  • Hemorrhoids (3)
  • Inflammatory Bowel Disease (10)
  • IBS (20)
  • Liver Disease (134)
    • Hepatitis B (2)
    • Hepatitis C (51)
    • Natural Medicines / Supplements (14)
    • Drug-Induced Liver Disease (67)
    • Monitoring (30)
  • Nausea & Vomiting (51)
  • Other (109)
  • Peptic Ulcer Disease (59)
  • Resources (144)
  • Ulcerative Colitis (4)
  • Ulcers (10)
31 - 45 of 51 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Patient Education: Breaking Ebola Myths December 2014
Other: Donning and Doffing Personal Protective Equipment December 2014
Article: Use Soap and Water After C. Difficile or Norovirus Exposure December 2014
Article: Watch for Acid-Reducer Interactions With New Hep C Med Harvoni December 2014
PL Voices: New Drugs for Treating Hepatitis C February 2014
Article: big changes in treating chronic hepatitis C with two new oral antivirals, Olysio (simeprevir) and Sovaldi (sofosbuvir) February 2014
PL Voices: Myths About Medication Use in Chronic Liver Disease October 2013
Article: myths perpetuated about meds in chronic liver disease October 2013
Patient Education: Staying Healthy While Abroad April 2013
Commentary: Identifying Hepatitis C Infection in Baby Boomers November 2012
Article: hepatitis C testing for ALL baby boomers November 2012
Article: two new protease inhibitors for hepatitis C, Incivek (telaprevir) and Victrelis (boceprevir) August 2011
Article: two new protease inhibitors for hepatitis C, Victrelis (vic-TREL-is) and Incivek (in-SEE-veck) July 2011
Commentary: Rifaximin (Xifaxan) for Hepatic Encephalopathy June 2010
Article: Xifaxan (rifaximin) is now approved for preventing hepatic encephalopathy due to chronic liver disease May 2010
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved